{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:58:08Z","timestamp":1794265088381,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670663"],"award-info":[{"award-number":["81670663"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1604284, 2016YFC1305404"],"award-info":[{"award-number":["U1604284, 2016YFC1305404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770672"],"award-info":[{"award-number":["81770672"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DK092485,DK114006"],"award-info":[{"award-number":["DK092485,DK114006"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ecdysone is an arthropod molting hormone and has been marketed as a non-androgenic natural anabolic and adaptogen. However, the safety profile of ecdysone is largely undetermined. After ecdysone treatment for 2 weeks, mice developed albuminuria with histologic signs of glomerular injury, including hypertrophy, mesangial expansion, mild glomerulosclerosis and podocyte injury. A direct glomerulopathic activity of ecdysone seems to contribute, since addition of ecdysone to cultured glomerular cells induced cytopathic changes, including apoptosis, activation of mesangial cells, podocyte shape changes and a decreased expression of podocyte markers. To explore the molecular target responsible for the pathogenic actions, we employed an <jats:italic>in silico<\/jats:italic> modeling system of compound-protein interaction and identified mineralocorticoid receptor (MR) as one of the top-ranking proteins with putative interactions with ecdysone. The molecular structure of ecdysone was highly homologous to mineralocorticoids, like aldosterone. Moreover, ecdysone was capable of both inducing and activating MR, as evidenced by MR nuclear accumulation in glomerular cells both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> following ecdysone treatment. Mechanistically, glycogen synthase kinase (GSK) 3\u03b2, which has been recently implicated in pathogenesis of glomerular injury and proteinuria, was hyperactivated in glomeruli in ecdysone-treated mice, concomitant with diverse glomerulopathic changes. In contrast, spironolactone, a selective blockade of MR, largely abolished the cytopathic effect of ecdysone <jats:italic>in vitro<\/jats:italic> and attenuated albuminuria and glomerular lesions in ecdysone treated mice, associated with a mitigated GSK3\u03b2 overactivity in glomeruli. Altogether, ecdysone seems able to activate MR and thereby promote glomerular injury and proteinuria involving overactive GSK3\u03b2 pathway signaling.<\/jats:p>","DOI":"10.1038\/s41598-018-29483-7","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T14:46:58Z","timestamp":1533826018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3\u03b2 pathway signaling"],"prefix":"10.1038","volume":"8","author":[{"given":"Minglei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangsuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"29483_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic Kidney Disease. Lancet. 389, 1238\u20131252 (2017).","journal-title":"Lancet."},{"key":"29483_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrneph.2012.42","volume":"8","author":"P Cravedi","year":"2012","unstructured":"Cravedi, P., Ruggenenti, P. & Remuzzi, G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol. 8, 301\u2013306 (2012).","journal-title":"Nat Rev Nephrol."},{"key":"29483_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg, A. Z. & Kopp, J. B. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 12, 502\u2013517 (2017).","journal-title":"Clin J Am Soc Nephrol."},{"key":"29483_CR4","doi-asserted-by":"publisher","first-page":"4632768","DOI":"10.1155\/2016\/4632768","volume":"2016","author":"B Sprangers","year":"2016","unstructured":"Sprangers, B., Meijers, B. & Appel, G. FSGS: Diagnosis and Diagnostic Work-Up. Biomed Res Int. 2016, 4632768 (2016).","journal-title":"Biomed Res Int."},{"key":"29483_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00428-012-1213-3","volume":"460","author":"SM Meehan","year":"2012","unstructured":"Meehan, S. M., Kim, L. & Chang, A. A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection. Virchows Arch. 460, 429\u2013435 (2012).","journal-title":"Virchows Arch."},{"key":"29483_CR6","first-page":"1630365","volume":"2016","author":"JS Kim","year":"2016","unstructured":"Kim, J. S., Han, B. G., Choi, S. O. & Cha, S. K. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis. Biomed Res Int. 2016, 1630365 (2016).","journal-title":"Biomed Res Int."},{"key":"29483_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semnephrol.2012.12.006","volume":"33","author":"C Wickman","year":"2013","unstructured":"Wickman, C. & Kramer, H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 33, 14\u201322 (2013).","journal-title":"Semin Nephrol."},{"key":"29483_CR8","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2215\/CJN.00300106","volume":"1","author":"JA Jaffe","year":"2006","unstructured":"Jaffe, J. A. & Kimmel, P. L. Chronic nephropathies of cocaine and heroin abuse: a critical review. Clin J Am Soc Nephrol. 1, 655\u2013667 (2006).","journal-title":"Clin J Am Soc Nephrol."},{"key":"29483_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2215\/CJN.03751106","volume":"2","author":"E Letavernier","year":"2007","unstructured":"Letavernier, E. et al. High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin J Am Soc Nephrol. 2, 326\u2013333 (2007).","journal-title":"Clin J Am Soc Nephrol."},{"key":"29483_CR10","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"GS Markowitz","year":"2001","unstructured":"Markowitz, G. S. et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 12, 1164\u20131172 (2001).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR11","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/ndt\/13.9.2234","volume":"13","author":"M Zeier","year":"1998","unstructured":"Zeier, M., Schonherr, R., Amann, K. & Ritz, E. Effects of testosterone on glomerular growth after uninephrectomy. Nephrol Dial Transplant. 13, 2234\u20132240 (1998).","journal-title":"Nephrol Dial Transplant."},{"key":"29483_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/sj.ki.5000058","volume":"69","author":"BO Eriksen","year":"2006","unstructured":"Eriksen, B. O. & Ingebretsen, O. C. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 69, 375\u2013382 (2006).","journal-title":"Kidney Int."},{"key":"29483_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ackd.2013.05.004","volume":"20","author":"J Neugarten","year":"2013","unstructured":"Neugarten, J. & Golestaneh, L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 20, 390\u2013395 (2013).","journal-title":"Adv Chronic Kidney Dis."},{"key":"29483_CR14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1681\/ASN.V112319","volume":"11","author":"J Neugarten","year":"2000","unstructured":"Neugarten, J., Acharya, A. & Silbiger, S. R. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 11, 319\u2013329 (2000).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/pcan.2009.24","volume":"13","author":"JP Lu","year":"2010","unstructured":"Lu, J. P. et al. Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase. Prostate Cancer Prostatic Dis. 13, 39\u201346 (2010).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"29483_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000119417","volume":"31","author":"T Kienitz","year":"2008","unstructured":"Kienitz, T. & Quinkler, M. Testosterone and blood pressure regulation. Kidney Blood Press Res. 31, 71\u201379 (2008).","journal-title":"Kidney Blood Press Res."},{"key":"29483_CR17","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1097\/01.ASN.0000033327.65390.CA","volume":"13","author":"O Baltatu","year":"2002","unstructured":"Baltatu, O. et al. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol. 13, 2681\u20132687 (2002).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1681\/ASN.2009040450","volume":"21","author":"LC Herlitz","year":"2010","unstructured":"Herlitz, L. C. et al. Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol. 21, 163\u2013172 (2010).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5604\/20831862.1144420","volume":"32","author":"MK Parr","year":"2015","unstructured":"Parr, M. K. et al. Ecdysteroids: A novel class of anabolic agents? Biol Sport. 32, 169\u2013173 (2015).","journal-title":"Biol Sport."},{"key":"29483_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/arch.20334","volume":"72","author":"L Dinan","year":"2009","unstructured":"Dinan, L. The Karlson Lecture. Phytoecdysteroids: what use are they? Arch Insect Biochem Physiol. 72, 126\u2013141 (2009).","journal-title":"Arch Insect Biochem Physiol."},{"key":"29483_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jinsphys.2012.01.013","volume":"58","author":"CC Schwedes","year":"2012","unstructured":"Schwedes, C. C. & Carney, G. E. Ecdysone signaling in adult Drosophila melanogaster. J Insect Physiol. 58, 293\u2013302 (2012).","journal-title":"J Insect Physiol."},{"key":"29483_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.1.06900","volume":"191","author":"L Dinan","year":"2006","unstructured":"Dinan, L. & Lafont, R. Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals. J Endocrinol. 191, 1\u20138 (2006).","journal-title":"J Endocrinol."},{"key":"29483_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/092986708783330674","volume":"15","author":"M Bathori","year":"2008","unstructured":"Bathori, M., Toth, N., Hunyadi, A., Marki, A. & Zador, E. Phytoecdysteroids and anabolic-androgenic steroids\u2013structure and effects on humans. Curr Med Chem. 15, 75\u201391 (2008).","journal-title":"Curr Med Chem."},{"key":"29483_CR24","first-page":"690","volume":"39","author":"VN Syrov","year":"1976","unstructured":"Syrov, V. N. & Kurmukov, A. G. Anabolic activity of phytoecdysone-ecdysterone isolated from Rhaponticum carthamoides (Willd.) Iljin. Farmakol Toksikol. 39, 690\u2013693 (1976).","journal-title":"Farmakol Toksikol."},{"key":"29483_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1254\/jjp.20.142","volume":"20","author":"M Masuoka","year":"1970","unstructured":"Masuoka, M., Orita, S., Shino, A., Matsuzawa, T. & Nakayama, R. Pharmacological studies of insect metamorphosing hormone: ponasterone A, ecdysterone, and inokosterone, in the rat. Jpn J Pharmacol. 20, 142\u2013156 (1970).","journal-title":"Jpn J Pharmacol."},{"key":"29483_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/path.4692","volume":"239","author":"C Li","year":"2016","unstructured":"Li, C., Ge, Y., Dworkin, L., Peng, A. & Gong, R. The beta isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy. J Pathol. 239, 23\u201335 (2016).","journal-title":"J Pathol."},{"key":"29483_CR27","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1681\/ASN.2015050565","volume":"27","author":"S Zhou","year":"2016","unstructured":"Zhou, S. et al. Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3beta Reinforces the Nrf2 Antioxidant Defense against Podocytopathy. J Am Soc Nephrol. 27, 2289\u20132308 (2016).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.toxlet.2005.06.005","volume":"158","author":"C Maravelias","year":"2005","unstructured":"Maravelias, C., Dona, A., Stefanidou, M. & Spiliopoulou, C. Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett. 158, 167\u2013175 (2005).","journal-title":"Toxicol Lett."},{"key":"29483_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1440-1681.1999.02996.x","volume":"26","author":"JF Reckelhoff","year":"1999","unstructured":"Reckelhoff, J. F. & Granger, J. P. Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol. 26, 127\u2013131 (1999).","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"29483_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0022-5347(06)00490-3","volume":"176","author":"PD Metcalfe","year":"2006","unstructured":"Metcalfe, P. D. & Meldrum, K. K. Sex differences and the role of sex steroids in renal injury. J Urol. 176, 15\u201321 (2006).","journal-title":"J Urol."},{"issue":"Suppl A","key":"29483_CR31","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.genm.2008.03.002","volume":"5","author":"S Silbiger","year":"2008","unstructured":"Silbiger, S. & Neugarten, J. Gender and human chronic renal disease. Gend Med. 5(Suppl A), S3\u2013S10 (2008).","journal-title":"Gend Med."},{"key":"29483_CR32","doi-asserted-by":"publisher","first-page":"R731","DOI":"10.1152\/ajpregu.00353.2006","volume":"292","author":"R Iliescu","year":"2007","unstructured":"Iliescu, R., Cucchiarelli, V. E., Yanes, L. L., Iles, J. W. & Reckelhoff, J. F. Impact of androgen-induced oxidative stress on hypertension in male SHR. Am J Physiol Regul Integr Comp Physiol. 292, R731\u2013735 (2007).","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"29483_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000099150","volume":"30","author":"BB McGuire","year":"2007","unstructured":"McGuire, B. B., Watson, R. W., Perez-Barriocanal, F., Fitzpatrick, J. M. & Docherty, N. G. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney. Kidney Blood Press Res. 30, 67\u201380 (2007).","journal-title":"Kidney Blood Press Res."},{"key":"29483_CR34","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/mnfr.201300806","volume":"58","author":"MK Parr","year":"2014","unstructured":"Parr, M. K. et al. Estrogen receptor beta is involved in skeletal muscle hypertrophy induced by the phytoecdysteroid ecdysterone. Mol Nutr Food Res. 58, 1861\u20131872 (2014).","journal-title":"Mol Nutr Food Res."},{"key":"29483_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","volume":"144","author":"CY Hsu","year":"2006","unstructured":"Hsu, C. Y., McCulloch, C. E., Iribarren, C., Darbinian, J. & Go, A. S. Body mass index and risk for end-stage renal disease. Ann Intern Med. 144, 21\u201328 (2006).","journal-title":"Ann Intern Med."},{"key":"29483_CR36","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.kint.2017.03.019","volume":"92","author":"QJ Lew","year":"2017","unstructured":"Lew, Q. J. et al. Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population. Kidney Int. 92, 979\u2013987 (2017).","journal-title":"Kidney Int."},{"key":"29483_CR37","first-page":"S124","volume":"63","author":"BM Brenner","year":"1997","unstructured":"Brenner, B. M. & Mackenzie, H. S. Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl. 63, S124\u2013127 (1997).","journal-title":"Kidney Int Suppl."},{"key":"29483_CR38","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1046\/j.1523-1755.2000.07505.x","volume":"75","author":"AB Fogo","year":"2000","unstructured":"Fogo, A. B. Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int Suppl. 75, S15\u201321 (2000).","journal-title":"Kidney Int Suppl."},{"key":"29483_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11906-006-0009-8","volume":"8","author":"RV Durvasula","year":"2006","unstructured":"Durvasula, R. V. & Shankland, S. J. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep. 8, 132\u2013138 (2006).","journal-title":"Curr Hypertens Rep."},{"key":"29483_CR40","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","volume":"69","author":"SJ Shankland","year":"2006","unstructured":"Shankland, S. J. The podocyte\u2019s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 69, 2131\u20132147 (2006).","journal-title":"Kidney Int."},{"key":"29483_CR41","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1681\/ASN.2017020174","volume":"28","author":"R Nishizono","year":"2017","unstructured":"Nishizono, R. et al. FSGS as an Adaptive Response to Growth-Induced Podocyte Stress. J Am Soc Nephrol. 28, 2931\u20132945 (2017).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR42","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1681\/ASN.2017060612","volume":"28","author":"VD D\u2019Agati","year":"2017","unstructured":"D\u2019Agati, V. D. Podocyte Growing Pains in Adaptive FSGS. J Am Soc Nephrol. 28, 2825\u20132827 (2017).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jis\/3.1.7","volume":"3","author":"R Lafont","year":"2003","unstructured":"Lafont, R. & Dinan, L. Practical uses for ecdysteroids in mammals including humans: an update. J Insect Sci. 3, 7 (2003).","journal-title":"J Insect Sci."},{"key":"29483_CR44","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.steroids.2010.03.008","volume":"75","author":"J Gorelick-Feldman","year":"2010","unstructured":"Gorelick-Feldman, J., Cohick, W. & Raskin, I. Ecdysteroids elicit a rapid Ca2+ flux leading to Akt activation and increased protein synthesis in skeletal muscle cells. Steroids. 75, 632\u2013637 (2010).","journal-title":"Steroids."},{"key":"29483_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrneph.2012.19","volume":"8","author":"I Helal","year":"2012","unstructured":"Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B. & Schrier, R. W. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 8, 293\u2013300 (2012).","journal-title":"Nat Rev Nephrol."},{"key":"29483_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1524-6175.2006.05110.x","volume":"8","author":"TL Goodfriend","year":"2006","unstructured":"Goodfriend, T. L. Aldosterone\u2013a hormone of cardiovascular adaptation and maladaptation. J Clin Hypertens (Greenwich). 8, 133\u2013139 (2006).","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"29483_CR47","doi-asserted-by":"publisher","first-page":"F1178","DOI":"10.1152\/ajprenal.00532.2009","volume":"298","author":"AS Brem","year":"2010","unstructured":"Brem, A. S. et al. Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11beta-HSD activity. Am J Physiol Renal Physiol. 298, F1178\u20131187 (2010).","journal-title":"Am J Physiol Renal Physiol."},{"key":"29483_CR48","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.steroids.2009.09.008","volume":"75","author":"W Thomas","year":"2010","unstructured":"Thomas, W., Dooley, R. & Harvey, B. J. Aldosterone as a renal growth factor. Steroids. 75, 550\u2013554 (2010).","journal-title":"Steroids."},{"key":"29483_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ki.2008.567","volume":"75","author":"AS Brem","year":"2009","unstructured":"Brem, A. S. The Janus effect: two faces of aldosterone. Kidney Int. 75, 137\u2013139 (2009).","journal-title":"Kidney Int."},{"key":"29483_CR50","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1681\/ASN.2007101079","volume":"19","author":"G Remuzzi","year":"2008","unstructured":"Remuzzi, G., Cattaneo, D. & Perico, N. The aggravating mechanisms of aldosterone on kidney fibrosis. J Am Soc Nephrol. 19, 1459\u20131462 (2008).","journal-title":"J Am Soc Nephrol."},{"key":"29483_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrneph.2010.30","volume":"6","author":"M Briet","year":"2010","unstructured":"Briet, M. & Schiffrin, E. L. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 6, 261\u2013273 (2010).","journal-title":"Nat Rev Nephrol."},{"key":"29483_CR52","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/ndt\/gft035","volume":"29","author":"E Ritz","year":"2014","unstructured":"Ritz, E. & Tomaschitz, A. Aldosterone and the kidney: a rapidly moving frontier (an update). Nephrol Dial Transplant. 29, 2012\u20132019 (2014).","journal-title":"Nephrol Dial Transplant."},{"key":"29483_CR53","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","volume":"37","author":"M Epstein","year":"2001","unstructured":"Epstein, M. Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications. Am J Kidney Dis. 37, 677\u2013688 (2001).","journal-title":"Am J Kidney Dis."},{"key":"29483_CR54","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ki.2011.48","volume":"79","author":"JP Bertocchio","year":"2011","unstructured":"Bertocchio, J. P., Warnock, D. G. & Jaisser, F. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Kidney Int. 79, 1051\u20131060 (2011).","journal-title":"Kidney Int."},{"key":"29483_CR55","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ki.2011.505","volume":"81","author":"L Shavit","year":"2012","unstructured":"Shavit, L., Lifschitz, M. D. & Epstein, M. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms. Kidney Int. 81, 955\u2013968 (2012).","journal-title":"Kidney Int."},{"key":"29483_CR56","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0002-9440(10)64239-3","volume":"161","author":"M Takemoto","year":"2002","unstructured":"Takemoto, M. et al. A New Method for Large Scale Isolation of Kidney Glomeruli from Mice. The American Journal of Pathology. 161, 799\u2013805 (2002).","journal-title":"The American Journal of Pathology."},{"key":"29483_CR57","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ki.2010.64","volume":"77","author":"D Veron","year":"2010","unstructured":"Veron, D. et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 77, 989\u2013999 (2010).","journal-title":"Kidney Int."},{"key":"29483_CR58","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.ajpath.2014.06.027","volume":"184","author":"W Xu","year":"2014","unstructured":"Xu, W., Ge, Y., Liu, Z. & Gong, R. Glycogen synthase kinase 3beta dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy. Am J Pathol. 184, 2742\u20132756 (2014).","journal-title":"Am J Pathol."},{"key":"29483_CR59","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/gutjnl-2013-306043","volume":"64","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y. et al. Therapeutic targeting of GSK3beta enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C. Gut. 64, 168\u2013179 (2015).","journal-title":"Gut."},{"key":"29483_CR60","doi-asserted-by":"publisher","first-page":"W492","DOI":"10.1093\/nar\/gkr299","volume":"39","author":"H Luo","year":"2011","unstructured":"Luo, H. et al. DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Res. 39, W492\u2013498 (2011).","journal-title":"Nucleic Acids Res."},{"key":"29483_CR61","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45, W356\u2013W360 (2017).","journal-title":"Nucleic Acids Res."},{"key":"29483_CR62","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ejmech.2016.11.035","volume":"126","author":"YC Duan","year":"2017","unstructured":"Duan, Y. C. et al. Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation. Eur J Med Chem. 126, 246\u2013258 (2017).","journal-title":"Eur J Med Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29483-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:37:07Z","timestamp":1671611827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29483-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29483-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"29 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12225"}}